KNBIF Stock - Kane Biotech Inc.
Unlock GoAI Insights for KNBIF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.08M | $148,980 | $2.67M | $1.61M | $1.34M |
| Gross Profit | $872,096 | $109,470 | $1.41M | $568,441 | $526,859 |
| Gross Margin | 41.9% | 73.5% | 53.0% | 35.4% | 39.3% |
| Operating Income | $-3,922,997 | $-3,357,386 | $-3,457,605 | $-4,883,557 | $-4,224,373 |
| Net Income | $6.10M | $-5,034,103 | $-3,889,892 | $-4,604,566 | $-3,716,686 |
| Net Margin | 293.0% | -3379.0% | -145.8% | -286.4% | -277.0% |
| EPS | $-0.02 | $-0.03 | $-0.03 | $-0.04 | $-0.03 |
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Visit WebsiteEarnings History & Surprises
KNBIFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 27, 2026 | — | — | — | — |
Q4 2025 | Nov 28, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 27, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 28, 2025 | — | $-0.01 | — | — |
Q1 2025 | Mar 28, 2025 | — | — | — | — |
Q4 2024 | Nov 26, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 29, 2024 | — | $0.04 | — | — |
Q2 2024 | May 23, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 26, 2024 | — | $-0.56 | — | — |
Q4 2023 | Nov 28, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 29, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 25, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 27, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 24, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 25, 2022 | — | $-0.01 | — | — |
Q2 2022 | May 26, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 24, 2022 | — | $-0.01 | — | — |
Q4 2021 | Nov 16, 2021 | — | $-0.01 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 27, 2021 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about KNBIF
What is KNBIF's current stock price?
What is the analyst price target for KNBIF?
What sector is Kane Biotech Inc. in?
What is KNBIF's market cap?
Does KNBIF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to KNBIF for comparison